Research To Practice | Oncology Videos

Latest Episodes:

Gastrointestinal Cancers| Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting Jun 27, 2022

Show notes

Featuring perspectives from Drs Tanios Bekaii-Saab, Kristen Ciombor, Eileen O'Reilly, Philip Philip, John Strickler and Prof Eric Van Cutsem, including the following topics:

Introduction (0:00)
Integration of targeted therapy and immunotherapy into the management of metastatic colorectal cancer — Kristen K Ciombor, MD, MSCI (3:15)
Other considerations in the management of early and advanced colorectal cancer — John Strickler, MD (33:15)
Current and future treatment paradigm for gastroesophageal cancers — Eric Van Cutsem, MD, PhD (55:26)
Selection and sequencing of therapy for advanced hepatocellular carcinoma — Philip A Philip, MD, PhD, FRCP (1:23:00)
Novel treatment strategies for advanced biliary tract cancers — Tanios Bekaii-Saab, MD (1:50:31)

CME information and select publications

Cervical and Endometrial Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress Jun 24, 2022

Show notes

Featuring perspectives from Ms Paula Anastasia, Dr Robert Coleman, Dr David O'Malley and Ms Jaclyn Shaver, including the following topics:

Introduction (0:00)
Management of Endometrial Cancer (5:32)
Treatment for Cervical Cancer (45:31)
COVID-19: Considerations in Cervical and Endometrial Cancer (1:22:34)
Oncology 2032 Crystal Ball (1:27:43)

CME information and select publications

Ovarian Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting Jun 23, 2022

Show notes

Featuring perspectives from Drs Antonio González-Martín, Joyce Liu and Kathleen Moore, including the following topics:

Introduction (0:00)
Clinical Management of Advanced Ovarian Cancer (2:23)
Novel Treatments and Strategies Under Investigation (46:04)

CME information and select publications

Prostate Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting Jun 22, 2022

Show notes

Featuring perspectives from Drs Andrew Armstrong, Alan Bryce and Alicia Morgans, including the following topics:

Introduction (0:00)
Case: A man in his early 70s with DIPSS low- to intermediate-risk post-essential thrombocythemia myelofibrosis (MF) — Warren S Brenner, MD (5:29)
Case: A woman in her late 60s with primary MF who experiences disease progression after 3 years of ruxolitinib — Jeanne Palmer, MD (17:19)
Case: A woman in her late 60s with disease progression after multiple regimens for post-polycythemia vera MF — Neil Morganstein, MD (30:51)
A woman in her late 70s with post-PV MF with a JAK2 V617F mutation and transfusion dependence — Bhavana (Tina) Bhatnagar, DO (39:33)
Case: A man in his mid 60s with primary MF with a JAK2 mutation and recurrent herpes zoster reactivation on ruxolitinib — Niyati A Nathwani, MD (50:23)
Case: A man in his early 70s with prefibrotic primary MF with a JAK2 mutation and ruxolitinib-associated HPV reactivation — Susannah Friemel, MD (53:36)
Case: A man in his early 20s with myeloproliferative neoplasm with a JAK2 V617F mutation and thrombocytosis — Rajni Sinha, MD, MRCP (57:16)

CME information and select publications

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 Jun 21, 2022

Show notes

Featuring perspectives from Prof Harry Yoon, including the following topics:

Introduction (0:00)
Case: A woman in her late 30s with Stage IIIA HER2-negative adenocarcinoma of the gastric antrum (pMMR, PD-L1 CPS
Case: A man in his mid 70s with metastatic esophageal adenocarcinoma (PD-L1 CPS 5) — Gurveen Kaur, MD (16:01)
Case: A man in his mid 70s with HER2-negative gastroesophageal junction adenocarcinoma with multiple brain metastases (microsatellite stable, PD-L1 CPS 10) — Neil Morganstein, MD (29:00)
Case: A man in his early 60s with HER2-positive esophageal adenocarcinoma (PD-L1 70%) — Kapisthalam (KS) Kumar, MD (42:19)
Case: A man in his early 60s with HER2-positive metastatic gastric cancer — Dr Morganstein (49:37)

CME information and select publications

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting Jun 20, 2022

Show notes

Featuring perspectives from Drs Courtney DiNardo, Michael Savona and Eunice Wang, including the following topics:

Introduction (0:00)
Selection of therapy for older and younger patients with acute myeloid leukemia (AML) (2:05)
Therapy for patients with AML with targetable mutations (33:42)
Current and future management of myelodysplastic syndromes (49:04)

CME information and select publications

Gastroesophageal Cancers | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Gastroesophageal Cancers Jun 17, 2022

Show notes

Featuring perspectives from Dr Kristen Ciombor and Ms Jessica Mitchell, including the following topics:

Introduction (0:00)
Management of localized disease (10:56)
Management of HER2-negative metastatic disease (34:36)
Management of HER2-positive metastatic disease (57:08)

NCPD information and select publications

Myelofibrosis | Meet The Professor: Current and Future Management of Myelofibrosis — Part 3 Jun 16, 2022

Show notes

Featuring perspectives from Dr John Mascarenhas, including the following topics: Introduction (0:00)

Case: A man in his mid 60s with post-PV myelofibrosis (MF) and ASXL1 and SRSF2 mutations — Jeanne Palmer, MD (22:40)
Case: A woman in her early 70s with high-risk primary MF and a CALR mutation (28:34)
Case: A woman in her mid 70s with primary MF with a JAK2 V617F mutation — Bhavana (Tina) Bhatnagar, DO (40:24)
Case: A woman in her early 50s with secondary MF with a JAK2 mutation — G Richard Polkinghorn, MD (43:30)
Case: A woman in her mid 80s with primary MF with an MPL mutation — Warren S Brenner, MD (47:01)
Case: A woman in her mid 80s with JAK2 mutation-positive primary MF with ASXL1 and U2F2 mutations with severe anemia — Neil Morganstein, MD (53:01)
Case: A woman in her mid 80s with MF with a JAK2 mutation and severe anemia — Paul Markowski, MD (56:44)

CME information and select publications

Chronic Lymphocytic Leukemia | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress Jun 14, 2022

Show notes

Featuring perspectives from Ms Lesley Camille Ballance, Ms Amy Goodrich, Dr Lowell Hart and Dr Anthony Mato, including the following topics:

Introduction (0:00)
Overview of Chronic Lymphocytic Leukemia (5:47)
Bruton Tyrosine Kinase Inhibitors (27:40)
Venetoclax and Anti-CD20 Antibody Therapy (58:59)
Future Strategies (1:15:51)

NCPD information and select publications

Urothelial Bladder Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress Jun 13, 2022

Show notes

Featuring perspectives from Ms Monica Averia, Dr Shilpa Gupta, Ms Brenda Martone and Dr Sumanta Kumar Pal, including the following topics:

Introduction (0:00)
Management of Localized Urothelial Bladder Cancer (UBC): Adjuvant Treatment, TAR-200 (6:47)
Management of Metastatic UBC: Antibody-Drug Conjugates, Checkpoint Inhibitors (33:00)
Management of UBC with an FGFR Mutation (57:37)
Oncology/UBC 2032 and a Crystal Ball (1:19:52)

NCPD information and select publications